Internal Medicine Alert – September 15, 2010
September 15, 2010
View Issues
-
One Screening Question to Help Identify Drug Use
In a sample of patients from primary care practice, a single screening question accurately identified drug use. -
Don't Get Too Tired — It's Bad for Your Heart
Vital exhaustion predicts long-term risk for adverse cardiac events in men and women, independent of established biomedical risk factors. -
Are Carbohydrates Worse Than Saturated Fat? A New Paradigm
Replacing saturated fatty acids with carbohydrates with low glycemic index values is associated with a lower risk of myocardial infarction. -
Olmesartan, Amlodipine, Hydrochlorothiazide Tablets (Tribenzor™)
A new three-drug antihypertensive pill, combining an angiotensin II receptor antagonist (olmesartan [OLM]), a calcium channel blocker (amlodipine [AML]), and a thiazide diuretic (hydrochlorothiazide [HCTZ]), has been approved by the FDA. The new combination is marketed by Daiichi Sankyo as Tribenzor. -
Clinical Briefs By Louis Kuritzky, MD
More than three-fourths of men have some degree of male pattern hair loss by age 70. The unwanted hair loss seen in male pattern hair loss is stimulated by dihydrotestosterone. -
ECG Review: An Interpolated Tracing
The ECG shown above was obtained from a 50-year-old woman with "skipped beats." Is there anything unusual about these ectopic beats and the effect that they have on the normal beats in this tracing? What happens at the onset of the last lead change (i.e., at the onset where we see leads V4,V5,V6)? -
Pharmacology Watch
Lorcaserin submitted for FDA review, FDA advisory panel votes against phentermine/topiramate, mixed vote on rosiglitazone, advisory panel votes to remove breast cancer indication from bevacizumab labeling, no increase in seizures found with DTaP vaccine, new REMS for quinine.